Fund
Viking Global Investors
Viking Global Investors led the round of TriGemX Bio (94 M$) on 1 October 2026. It is the only health round Bolus has logged for it so far.
Page built from the operations logged, not from a written profile. It says nothing about the fund's activity outside the scope of Bolus, which is health venture capital in Europe and the United States.
- Operations logged
- 1
- Lead
- 1
- New entries
- 0
- Follow ons
- 0
- Latest operation
- 1 October 2026
- Sectors
- Biotech
Operations
| Date | Company | Stage | Amount | Role |
|---|---|---|---|---|
| 01 Oct | United States, Biotech | Undisclosed | 94 M$ | Lead |
Co investors 2 funds crossed
Funds that appeared in the same rounds, in any capacity. Geographies logged: United States.